Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Stuve, W.
Wessels, A.
and
Timmerman, L.
2004.
Remisión de los síntomas positivos de una psicosis esquizofrénica después de suprimir la lamotrigina: un informe clínico.
European psychiatry (Ed. Española),
Vol. 11,
Issue. 3,
p.
194.
Chan, Yiu-Chung
Miller, Karla M.
Shaheen, Natalie
Votolato, Nicholas A.
and
Hankins, Mary Beth
2005.
Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: A case report.
Schizophrenia Research,
Vol. 78,
Issue. 2-3,
p.
343.
Konstantakopoulos, George
Oulis, Panagiotis
Michalopoulou, Panagiota G.
Koulouris, George C.
and
Masdrakis, Vasilios G.
2008.
Lamotrigine-associated exacerbation of positive symptoms in paranoid schizophrenia.
Schizophrenia Research,
Vol. 98,
Issue. 1-3,
p.
325.
Citrome, Leslie
2008.
Antiepileptic Drugs to Treat Psychiatric Disorders.
p.
187.
Citrome, Leslie
2009.
Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?.
Expert Review of Neurotherapeutics,
Vol. 9,
Issue. 1,
p.
55.
Zhand, Naista
Attwood, David G.
and
Harvey, Philip D.
2019.
Glutamate modulators for treatment of schizophrenia.
Personalized Medicine in Psychiatry,
Vol. 15-16,
Issue. ,
p.
1.
Comments
No Comments have been published for this article.